ASHG is deeply troubled by the recent layoffs at a number of agencies. The impact on scientific progress and innovation is profound and alarming.
Read our statement: https://t.co/51Iv0h6hkp
Join our next Ethox Seminar -
🧠Automated prejudice: Should algorithms assess risk in the criminal justice system?⚖️
🗣️@HopeKent20
���Thur, 3 Oct 2024, 2:30 to 4.00pm
🏢Richard Doll Building(Old Road Campus) & Online Details & Zoom ⬇️
https://t.co/ieaiNXxrl5
DCE from 12 European countries on public preferences for health data sharing governance: Heterogeneity of preferences and necessity of governance flexibility. Please consider in @ehds2pilot and @EU_Health. https://t.co/y98WfDMe8T @rosie_open@HYBRIDA_H2020@UniOslo_MED#EHDS
Unser erstes Ziel sind 20.000 Euro und wir haben bereits mehr als die Hälfte erreicht. Bitte beteiligt Euch, wenn Ihr könnt. Ein Beirat, u.a. mit @BirgitHebein, @BPrainsack & @JulyaRabinowich, entscheidet über die Mittelverwendung. Hier gibts Infos: https://t.co/y4wYCLFLSH (2)
@marcus_baw This is especially dangerous for patients that may not understand where options come from and do not distinguish between adv. and actual information
This is why we need a more nuanced assessment of the public value emerging from research, instead of sticking with the dichotomy between research being “in the public interest” or not: https://t.co/yTyLMYc6nb
(See also https://t.co/hRkB56pOr7)
Time to celebrate! @ENLIGHTENme_EU will be awarded the URBES award given to cities, institutions, foundations and people who have promoted #urbanhealth and wellbeing with their commitment and targeted projects @Horizon_EU
👉https://t.co/yX7CVNRLIA
We are starting a wonderful day full of discussions at the 2nd WG meeting of @COSTprogramme Action CA21151 @HaploiPS in Sofia, 🇧🇬! HAPLO-iPS aims to create a collaborative network to provide a framework for hiPSC generation.
⁉️𝐖𝐡𝐚𝐭 𝐢𝐬 𝐅𝐀𝐂𝐈𝐋𝐈𝐓𝐀𝐓𝐄'𝐒 𝐎𝐕𝐄𝐑𝐀𝐋𝐋 𝐆𝐎𝐀𝐋?
The overall goal of this 4years project is the development of a patient centered process prototype to allow the direct generation and the return of clinical trials data to study participants👉https://t.co/TWvYKTm88U
FACILITATE’s project partners here together in #Paris for a Semi-annual meeting discussing how to return data to study participants & secondary use of these data!
To be updated join #FACILITATE's pool of stakeholders here! 👉https://t.co/TXNaUwS6dX